ClassID:

94856

C07D295/033 - CPC Classification

Classification description:

Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings

Recent Application in this class:
#1
20250376443
2025-12-11

MASP-2 INHIBITORS AND METHODS OF USE

#2
20250368604
2025-12-04

MASP-2 INHIBITORS AND METHODS OF USE

#3
20250236638
2025-07-24

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

#4
20250129020
2025-04-24

MASP-2 INHIBITORS AND METHODS OF USE

#5
20240383852
2024-11-21

ANTI-VIRAL COMPOUNDS

#6
20240287009
2024-08-29

AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME

#7
20230365539
2023-11-16

NOVEL CHALCONE-BASED CHEMOTHERAPEUTIC COMPOUND FOR TRIPLE NEGATIVE BREAST CANCER

#8
20230192757
2023-06-22

Compositions and methods for treating CNS disorders

#9
20230145071
2023-05-11

MASP-2 inhibitors and methods of use

#10
20220324806
2022-10-13

Cannabinoid derivatives

#11
20220098143
2022-03-31

CAPSAICIN AND TRPV1 MODULATOR COMBINATIONS AND METHODS OF USE THEREOF

#12
20210276966
2021-09-09

Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors

#13
20210115002
2021-04-22

Prodrug compounds activated by AKR1C3 and their use for treating hyperproliferative disorders

#14
20210094910
2021-04-01

Drug for treating tumor diseases and having antibacterial antivirus anti-inflammatory effects

#15
20210087223
2021-03-25

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

#16
20210087155
2021-03-25

AN IMPROVED PROCESS FOR THE PREPARATION OF VORTIOXETINE AND SALTS THEREOF

#17
20200392119
2020-12-17

Chalcone-based chemotherapeutic compound for triple negative breast cancer

#18
20200354482
2020-11-12

Modified conjugated diene-based polymer and rubber composition including the same

#19
20200172523
2020-06-04

Process and intermediates for the preparation of benzo[b]thiophene compounds

#20
20200062696
2020-02-27

COMPOSITIONS AND METHODS FOR INHIBITING RETICULON 4

#21
20200024301
2020-01-23

Compositions and methods for treating CNS disorders

#22
20200017508
2020-01-16

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#23
20190367452
2019-12-05

MASP-2 inhibitors and methods of use

#24
20190254991
2019-08-22

Nicotinic receptor non-competitive antagonists

#25
20190177265
2019-06-13

METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND

#26
20190040048
2019-02-07

Process and intermediates for the preparation of benzo[b]thiophene compounds

#27
20190040028
2019-02-07

ARYLATION OF ALIPHATIC AMINES

#28
20190040027
2019-02-07

Synthesis of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine

#29
20180271806
2018-09-27

Nicotinic receptor non-competitive antagonists

#30
20180127389
2018-05-10

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#31
20180118646
2018-05-03

Method for producing aromatic compound

#32
20170282170
2017-10-05

PHOSPHORUS-CONTAINING CATALYSTS

#33
20170152391
2017-06-01

Compound, active energy ray curable composition, cured article thereof, printing ink, and inkjet recording ink

#34
20160263566
2016-09-15

Phosphine ligands for catalytic reactions

#35
20160257661
2016-09-08

1,4-cyclohexylamine derivatives and processes for the preparation thereof

#36
20160207034
2016-07-21

PHOSPHORUS-CONTAINING CATALYSTS

#37
20160152583
2016-06-02

Composite containing catalytic metal nanoparticles, and use for same

#38
20160152554
2016-06-02

Method for producing 2-(4-N,N-dialkylamino-2-hydroxybenzoyl) benzoates

#39
20160137620
2016-05-19

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#40
20160137592
2016-05-19

Compounds advantageous in the treatment of central nervous system diseases and disorders

#41
20160039676
2016-02-11

Fullerene derivatives and their applications in organic photovoltaics

#42
20160008323
2016-01-14

Nicotinic receptor non-competitive antagonists

#43
20150360215
2015-12-17

Phosphine ligands for catalytic reactions

#44
20150360214
2015-12-17

Reaction catalyst for cross-coupling and method for manufacturing aromatic compound

#45
20150152216
2015-06-04

Silicon-based cross coupling agents and methods of their use

#46
20150152126
2015-06-04

Phosphine ligands for catalytic reactions

#47
20150099714
2015-04-09

Synthesis of deuterated morpholine derivatives

#48
20140371446
2014-12-18

Phosphine ligands for catalytic reactions

#49
20140330012
2014-11-06

Paracyclophane-based ligands, their preparation and use in catalysis

#50
20140315877
2014-10-23

NICOTINIC RECEPTOR NON-COMPETITIVE ANTAGONISTS

#51
20140213785
2014-07-31

Process for preparing aromatic and heteroaromatic amines

#52
20140088095
2014-03-27

Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound

#53
20140039181
2014-02-06

Method for producing N-substituted amine compounds through catalyzed alkylation

#54
20130289270
2013-10-31

Amination of aryl alcohol derivatives

#55
20120302553
2012-11-29

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#56
20120273768
2012-11-01

Heterocycle-containing asymmetric aromatic compound, compound for organic thin film transistor, and organic thin film transistor using the same

#57
20120252789
2012-10-04

Inhibitors of sphingosine kinase

#58
20120129889
2012-05-24

Non-competitive NMDA receptor antagonists

#59
20120095007
2012-04-19

Carbamoyloxy arylalkan arylpiperazine analgesics

#60
20120022252
2012-01-26

Phosphine ligands for catalytic reactions

#61
20110313158
2011-12-22

Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines

#62
20110269775
2011-11-03

Piperazine derivatives

#63
20110263862
2011-10-27

PIPERIDINE DERIVATIVE, PIPERAZINE DERIVATIVE AND AGENT FOR TREATMENT OF DISEASE INVOLVING CENTRAL NERVOUS SYSTEM DISORDERS

#64
20110218205
2011-09-08

Piperazine derivatives

#65
20110195963
2011-08-11

Carbamoyloxy arylalkanoyl arylpiperazine analgesics

#66
20110178199
2011-07-21

Method for producing organic compound and organic compound obtained by the method

#67
20110028718
2011-02-03

Paracyclophane-based ligands, their preparation and use in catalysis

#68
20110009423
2011-01-13

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#69
20100311734
2010-12-09

Spiro Compounds Useful as Antagonists of the H1 Receptor

#70
20100305088
2010-12-02

Inhibitors of the chemokine receptor CxCR3

#71
20100279340
2010-11-04

Imaging agents for protein misfolding

#72
20100233629
2010-09-16

Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition

#73
20100160331
2010-06-24

NOVEL CARBAMOYLOXY ARYLALKAN ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND

#74
20100160247
2010-06-24

Synthesis of deuterated morpholine derivatives

#75
20100048531
2010-02-25

GlyT1 receptor antagonists

#76
20090264435
2009-10-22

Novel Aryl- and Heteroarylpiperazines

#77
20090239873
2009-09-24

Phenyl-piperazine derivatives as modulators of muscarinic receptors

#78
20090163715
2009-06-25

Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound

#79
20090156589
2009-06-18

1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE

#80
20090143395
2009-06-04

Piperazine derivatives

#81
20080255137
2008-10-16

N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto

#82
20080176856
2008-07-24

Novel Alkyl Substituted Piperidine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors

#83
20080039498
2008-02-14

Non-competitive NMDA receptor antagonists

#84
20080033171
2008-02-07

Ligands for metals and improved metal-catalyzed processes based thereon

#85
20070191340
2007-08-16

Compounds which modulate the CB2 receptor

#86
20070179155
2007-08-02

N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases

#87
20070149544
2007-06-28

Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation

#88
20070060574
2007-03-15

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#89
20070049571
2007-03-01

Dipiperazinyl ketones and related analogues

#90
20060281747
2006-12-14

1,2-di(cyclic) substituted benzene derivatives

#91
20060276465
2006-12-07

1,2-di(cyclic) substituted benzene compounds

#92
20060264673
2006-11-23

Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds

#93
20060264528
2006-11-23

Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition

#94
20060089368
2006-04-27

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#95
20060084662
2006-04-20

Phenyl-piperazine derivatives as serotonin reuptake inhibitors

#96
20060069257
2006-03-30

Ligands for metals and improved metal-catalyzed processes based thereon

#97
20060009448
2006-01-12

Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one

#98
20050288304
2005-12-29

Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists

#99
20050282871
2005-12-22

3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors

#100
20050250743
2005-11-10

Ammonium salts of inositol hexaphosphate, and uses thereof

#101
20050215794
2005-09-29

Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

#102
20050215563
2005-09-29

Proteomimetic compounds and methods

#103
20050137211
2005-06-23

Phenyl-piperazine derivatives as modulators of muscarinic receptors

#104
20050080090
2005-04-14

Naphthalene derivatives

#105
20050075344
2005-04-07

Melanocortin receptor agonists

#106
20050049146
2005-03-03

Use of substituted dibenzothiepine derivatives as insecticidal, acaricidal and nematicidal agents

#107
20050038035
2005-02-17

Heterocyclic amide compounds as apolipoprotein b inhibitors

#108
20050014822
2005-01-20

Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use

#109
20050014740
2005-01-20

Phenyl-piperazine derivatives as serotonin reuptake inhibitors